Bavarian Nordic AS

BV3

Company Profile

  • Business description

    Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

  • Contact

    Philip Heymans Alle 3
    Hellerup2900
    DNK

    T: +45 33268383

    E: [email protected]

    https://www.bavarian-nordic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,653

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,462.6040.900.49%
CAC 407,743.7549.310.64%
DAX 4023,499.32146.630.63%
Dow JONES (US)41,249.38119.07-0.29%
FTSE 1008,554.8023.190.27%
HKSE22,867.7491.820.40%
NASDAQ17,928.920.780.00%
Nikkei 22537,503.33574.701.56%
NZX 50 Index12,605.07138.041.11%
S&P 5005,659.914.03-0.07%
S&P/ASX 2008,231.2039.500.48%
SSE Composite Index3,342.0010.00-0.30%

Market Movers